Business-and-investment

CHIKUNGUNYA VACCINE DEVELOPMENT TOWARDS PHASE III …
Vienna, 5th September 2017 – The further development of a promising Chikungunya vaccine candidate by Themis Bioscience is now supported with 3 Mio. GBP by the United Kingdom’s innovation agency, Innovate UK. Themis, the Vienna-based specialist for vaccine development, will use these funds to identify and validate a correlate of protection for its prophylactic Chikungunya vaccination candidate. Currently the candidate…
Read More
Lyophilisation USA 27th April to 28th April 2016,…
SMi Group are thrilled to present the 2nd annual Lyophilization USA conference, returning to Iselin, New Jersey on April 27th & 28th 2016. With an increase in contract services, combination products and innovative drug delivery devices, growing demand for lyophilization equipment and lyophilized biopharmaceuticals has contributed to a projected rise in market growth from US $2.0 billion in 2013 to US $4.8 billion by…
Read More
Pre-Filled Syringes June 6-7th 2016, San Diego, US…
SMi proudly presents its inaugural event of the premier Pre-Filled Syringes series to San Diego in June 2016! The prefilled syringes (PFS) market is poised to account for exponential growth and account for $6 billion revenue by the end of 2020.* The market has witnessed continual advancements in device design with enhanced safety and usability by patients through human factor engineering.

Go to this site to read more about how technology has helped the healthcare industry to grow. Technology has changed every aspect of our lives. Be it how we listen to music or how we exercise and shop. Healthcare technology helps people to live longer. It also reduces the waiting time that makes it easy for the doctors to diagnose any diseases.

Nonetheless, challenges surrounding…
Read More
Zedira receives further funding to develop Factor …
Zedira has received further funding from the German Federal Ministry for Education and Research (German abbreviation: BMBF). The project volume has been extended by € 1.0 Mio. so that the total project value exceeds € 5.0 Mio. by now. The additional funding will allow completing the development of a drug candidate for „safe“ anticoagulation. Zedira targets coagulation factor XIIIa (F13, plasma transglutaminase) using…
Read More
Seegene Receives FDA Clearance for its Herpes Simp…
Gaithersburg, Maryland and SEOUL, Korea, February 17, 2015 – Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance for its TOCE™-based herpes simplex virus (HSV) types 1 and 2 assay. This is the first product that Seegene has taken through the FDA, and it opens the way for Seegene’s other…
Read More
Stem Cell Summit April 27-29, 2015 Boston, MA
We invite you to attend the Stem Cell Summit 2015 taking place on April 27 – 29, 2015 in Boston, MA at the Hyatt Regency Boston Hotel. This summit includes two parallel conferences which include joint sessions. GTCbio’s Stem Cell Summit 2015 provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, product development and…

Share:

You might also like …